<--- Back to Details
First PageDocument Content
Business / Companies listed on the New York Stock Exchange / Valeant Pharmaceuticals / Biovail / SEC filings / Corporate finance / Proxy statement / Mergers and acquisitions / Dividend / Stock market / Financial economics / Investment
Date: 2012-03-27 10:07:02
Business
Companies listed on the New York Stock Exchange
Valeant Pharmaceuticals
Biovail
SEC filings
Corporate finance
Proxy statement
Mergers and acquisitions
Dividend
Stock market
Financial economics
Investment

ACE BOWNE OF NEW YORK[removed]:03 NO MARKS

Add to Reading List

Source URL: www.valeant.com

Download Document from Source Website

File Size: 1,62 MB

Share Document on Facebook

Similar Documents

May 2, 2018 Response of the Office of Mergers and Acquisitions Division of Corporation Finance Adam T. Teufel, Esq. Dechert LLP

DocID: 1vfZJ - View Document

LEM WORKING PAPER SERIES Do Intellectual Property Rights Influence Cross-Border Mergers and Acquisitions?

DocID: 1vdQC - View Document

#49 - Mergers and Acquisitions (M&A) (State) Personas: Version 1, DeliveredBackground: This journey captures the experiences of two state-licensed companies combining as a result of a publicly announced

DocID: 1uRl3 - View Document

Cameron McKenzie, CVA, CM&AA, founder of McKenzie & Associates, LLC, a financial advisory firm, has advised public and private corporations in mergers and acquisitions, capital raises, corporate restructuring and busines

DocID: 1u6Hz - View Document

Mergers and Acquisitions: an Introduction Discussion document January 14, 2010

DocID: 1tpJJ - View Document